Infection Control Program Failed to Identify and Track Scabies Cases
Summary
The facility failed to establish, maintain, and implement an effective infection prevention and control program to identify, monitor, investigate, and prevent the transmission of communicable disease after multiple residents developed signs and symptoms consistent with scabies. The infection prevention and control policies identified the Infection Preventionist as responsible for surveillance, epidemiological investigation, isolation precautions, resident placement, monitoring exposures, and consultation to staff, but the facility’s surveillance documentation did not show a systematic process for identifying infection trends, recognizing clusters of residents with similar symptoms, or implementing timely corrective actions. The Infection Preventionist confirmed that residents with persistent rashes and itching were not included on the monthly infection surveillance logs as suspected or confirmed infections, that the facility did not complete a facility-wide skin assessment until July 3, 2026, and that there was no documentation of staff exposure assessments or contact tracing. Resident 1, who had congestive heart failure, diabetes mellitus, and anxiety and a BIMS score of 12, repeatedly complained of generalized itching beginning in February 2026. Nursing staff and the CRNP treated the resident with multiple antihistamines, topical steroids, prednisone, and later dermatology referral, but the itching and rash persisted for months. Dermatology noted persistent itching involving the arms, neck, breasts, and trunk and later prescribed Permethrin 5% cream, followed by Ivermectin after continued symptoms. Resident 2, who was cognitively intact, developed a rash involving the upper extremities and trunk in April 2026 and continued to have itching despite multiple topical treatments. Dermatology biopsy results confirmed scabies, and Permethrin was ordered, but the record did not document removal of the medication after the recommended application period. Resident 3, who had chronic pain, diabetes mellitus, difficulty walking, and a BIMS score of 13, developed itching and a rash involving the back, buttocks, legs, lower back, and trunk beginning in May 2026. The resident was treated as having contact dermatitis with hydrocortisone, triamcinolone, and other medications, but symptoms persisted until dermatology evaluation and biopsy confirmed scabies in June 2026. Resident 4, who had diabetes mellitus, arthritis, and a BIMS score of 12, reported persistent itching and inability to sleep, was treated with hydroxyzine, and later refused Permethrin before dermatology confirmed scabies involving the trunk. Resident 5, who had a cerebrovascular accident, dementia, diabetes mellitus, and a BIMS score of 12, had persistent rash and itching despite two courses of Permethrin; dermatology later obtained a skin scraping and biopsy confirming scabies and recommended Ivermectin. Facility-wide skin assessments later identified sixteen residents with body rashes, and the documentation showed ongoing treatment with little or no improvement in symptoms.
Penalty
Resources
Below are regulatory guidelines relevant to this citation:
Trusted data from CMS and state health departments
Every citation, penalty and Plan of Correction is sourced from public CMS records (latest release October 8, 2026) and official state health department websites — never guesswork.
In your survey window? See what surveyors are citing.
The Survey-Prep Report maps your facility's risk from 12 months of CMS and state citation data — what's being cited around you and what to check first. $129 one-time.